These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1999717)

  • 1. Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration.
    Feun LG; Gonzalez R; Savaraj N; Hanlon J; Collier M; Robinson WA; Clendeninn NJ
    J Clin Oncol; 1991 Mar; 9(3):464-7. PubMed ID: 1999717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of piritrexim and DTIC using an alternating dose schedule in metastatic melanoma.
    Feun LG; Robinson WA; Savaraj N; Gonzalez R; Liebmann A; Offenhauser K; Clendeninn NJ
    Am J Clin Oncol; 1995 Dec; 18(6):488-90. PubMed ID: 8526190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder.
    Khorsand M; Lange J; Feun L; Clendeninn NJ; Collier M; Wilding G
    Invest New Drugs; 1997; 15(2):157-63. PubMed ID: 9220296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of piritrexim capsules using prolonged, low-dose oral administration for the treatment of advanced malignancies.
    Feun LG; Savaraj N; Benedetto P; Hanlon J; Sridhar KS; Collier M; Richman S; Liao SH; Clendeninn NJ
    J Natl Cancer Inst; 1991 Jan; 83(1):51-5. PubMed ID: 1984518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule.
    Adamson PC; Balis FM; Miser J; Arndt C; Wells RJ; Gillespie A; Aronson L; Penta JS; Clendeninn NJ; Poplack DG
    Cancer Res; 1992 Feb; 52(3):521-4. PubMed ID: 1732038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II and pharmacokinetic study with oral piritrexim for metastatic breast cancer.
    de Vries EG; Gietema JA; Workman P; Scott JE; Crawshaw A; Dobbs HJ; Dennis I; Mulder NH; Sleijfer DT; Willemse PH
    Br J Cancer; 1993 Sep; 68(3):641-4. PubMed ID: 8353055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.
    Bleehen NM; Newlands ES; Lee SM; Thatcher N; Selby P; Calvert AH; Rustin GJ; Brampton M; Stevens MF
    J Clin Oncol; 1995 Apr; 13(4):910-3. PubMed ID: 7707118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma.
    Pyrhönen S; Hahka-Kemppinen M; Muhonen T
    J Clin Oncol; 1992 Dec; 10(12):1919-26. PubMed ID: 1280673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of tauromustine administered in a weekly schedule.
    Gjedde SB; Mouridsen HT; L-Madsen E; Jensen NV; Blomquist E; Bergh J; Söderberg M; Wählby S
    Eur J Cancer; 1993; 29A(13):1901-2. PubMed ID: 8260251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral piritrexim, an effective treatment for metastatic urothelial cancer.
    de Wit R; Kaye SB; Roberts JT; Stoter G; Scott J; Verweij J
    Br J Cancer; 1993 Feb; 67(2):388-90. PubMed ID: 8431372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
    Alberts DS; Mackel C; Pocelinko R; Salmon SE
    Cancer Res; 1982 Mar; 42(3):1170-5. PubMed ID: 7037174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.
    Gasparini G; Caffo O; Barni S; Frontini L; Testolin A; Guglielmi RB; Ambrosini G
    J Clin Oncol; 1994 Oct; 12(10):2094-101. PubMed ID: 7931479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma.
    Hamid O; Ilaria R; Garbe C; Wolter P; Maio M; Hutson TE; Arance A; Lorigan P; Lee J; Hauschild A; Mohr P; Hahka-Kemppinen M; Kaiser C; Turner PK; Conti I; Grob JJ
    Cancer; 2014 Jul; 120(13):2016-24. PubMed ID: 24676877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
    Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
    Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule.
    Adamson PC; Balis FM; Miser J; Wells RJ; Bleyer WA; Williams TE; Gillespie A; Penta JS; Clendeninn NJ; Poplack DG
    Cancer Res; 1990 Aug; 50(15):4464-7. PubMed ID: 2369724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of cisplatin and alpha-interferon in advanced malignant melanoma.
    Margolin KA; Doroshow JH; Akman SA; Leong LA; Morgan RJ; Somlo G; Raschko J; Pereira C; Yonemoto L; Ahn C
    J Clin Oncol; 1992 Oct; 10(10):1574-8. PubMed ID: 1403037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I clinical and pharmacological study of weekly intravenous infusions of piritrexim (BW301U).
    Weiss GR; Sarosy GA; Shenkenberg TD; Williams T; Clendeninn NJ; Von Hoff DD; Woolley JL; Liao SH; Blum MR
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1867-73. PubMed ID: 2632268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of tauromustine in disseminated malignant melanoma.
    Nolte H; Gjedde SB; Lindegaard-Madsen E; Bergh J; Blomquist E; Mouridsen HT
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):655-7. PubMed ID: 2714342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma.
    Alatrash G; Hutson TE; Molto L; Richmond A; Nemec C; Mekhail T; Elson P; Tannenbaum C; Olencki T; Finke J; Bukowski RM
    J Clin Oncol; 2004 Jul; 22(14):2891-900. PubMed ID: 15254058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma.
    Bleehen NM; Newman HV; Rampling RP; Ramsay JR; Roberts JT; Bedford P; Nethersell AB
    Br J Cancer; 1995 Sep; 72(3):766-8. PubMed ID: 7669591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.